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Lateral thinking
For those of us used to hearing with
our ears, it is difficult to imagine how
the fish or amphibian perceives its
environment on the basis of
information from the lateral line
sensory system. The lateral line
system detects vibrations in the
water, a process that has been termed
‘svenning’ — after Sven Dijkgraaf
(1908–1995), a founder figure in
lateral line research — and is neatly
summarised in the poem [1]:
Dear frog and fish, or newt and shark,
You needn’t worry when it’s dark;
You’ll escape or dine just fine,
Svenning with your lateral line.
The scanning electron micrograph
above shows the neuromasts and
pores of the lateral line canal system.
The canals themselves can be seen
in the lower image. (Images of
Xiphister mucosus provided by Chris
Braun and Sheryl Coombs, Parmly
Hearing Institute, Loyola University
Chicago, Illinois 60626, USA.)
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In their recent review [1], Ptashne
and Gann have articulated a
regulated localization model for gene
expression in which a typical
transcriptional activator functions as
a ‘locator’ that recruits, or localizes,
the transcription machinery to a
site — a specific promoter — that is
dictated by the DNA-binding
address of the activator. They
extended this mechanism to other
biological processes, including the
regulated localization of signal
transduction proteins to the
intracellular domains of
transmembrane receptors, and argue
that the strategy comprises a highly
‘evolvable’ system for interpreting
physiological signals. Here, we note
that several of the key attributes of
regulated localization as found in
transcription are also found in the
control of alternative splicing of
metazoan pre-messenger RNAs.
Pre-mRNAs containing multiple
introns and exons can be
alternatively spliced by joining
different pairs of 5′ and 3′ splice
sites. Splice site choice is controlled
by the activities of splicing
enhancers — regulatory elements
usually located within the exon
downstream of the regulated intron
(see [2–5] for recent reviews).
Splicing enhancers are recognized by
a family of essential splicing factors
called SR proteins (serine/arginine-
rich). Each splicing enhancer is
thought to be recognized by a unique
subset of one or more SR proteins.
Recent studies have provided some
interesting insights.
Firstly, just as the specificity of
various transcriptional regulators is
determined solely by their address on
DNA, so is the specificity of action of
SR proteins determined solely by
their address on RNA [6–9]. Thus,
any of a variety of enhancer
sequences placed near a weak splice
site will promote its recognition by
the splicing machinery in the
presence of the appropriate SR
protein(s) (Figure 1a).
Secondly, like transcriptional
activators, SR proteins bear separable
‘activating’ and nucleic acid binding
domains. Specifically, SR proteins
consist of an arginine/serine-rich
protein interaction domain (RS
domain) and one or more RNA-
binding domains [2,4]. Hybrid
proteins comprising an RS domain
fused to the bacteriophage MS2
RNA-binding protein activate the
splicing of an intron in which the
normal splicing enhancer has been
replaced by an MS2 RNA-binding
site (Figure 1b) [10]. Moreover, any
one of the RS domains of the six
human SR proteins tested in these
hybrid proteins activates splicing of
the test RNA [11].
Thirdly, experiments performed
in vitro suggest that SR proteins work
by recruiting the splicing machinery
to the nearby splice site [12].
Consistent with this view, an RS
domain that is not attached to an
RNA-binding domain is incapable of
functioning as a splicing activator
(B.R.G. and T.M., unpublished data).
Fourthly, the activating regions of
SR proteins share a remarkable
property with transcription activating
regions: as they are shortened by
deletion they continue to function at
a level approximately proportional to
their lengths [11,13]. In the case of
SR proteins, the activity is directly
proportional to the number of RSRS
tetrapeptides [11]. Although this
property is not yet understood in
detail, it strongly suggests that,
rather than performing some
enzymatic function, these peptides
work by a simple tethering
(recruiting) mechanism. Consistent
R6 Current Biology, Vol 9 No 1
with this idea, typical enhancers
(both transcriptional and splicing)
work less well as their distance to the
target site is increased and as the
number of bound proteins decreases
[11,14,15]. A possible difference,
however, between transcriptional
and splicing enhancers is that
multiple copies of the former lead to
a synergistic increase in activity [15],
whereas multiple copies of the latter
are additive [11,14]. Thus, whereas
transcriptional enhancer complexes
can simultaneously interact with
multiple targets in the transcription
machinery, splicing enhancer
complexes can interact with only one
target in the splicing machinery at a
time [11,14]. Therefore, multiple
splicing enhancers appear to increase
the probability of an interaction with
the splicing machinery, but do not
provide functional synergy. 
Finally, as in the case of
transcriptional enhancers,
cooperativity can be used to regulate
the assembly of multi-component
splicing enhancer complexes. The
sex-specific splicing enhancer of the
Drosophila doublesex pre-mRNA, for
example, is recognized by an SR
protein called RBP1 and a splicing
regulator called Transformer 2 (Tra2)
[16]. Efficient binding of these
proteins to the enhancer, however,
requires another protein called
Transformer (Tra) which is expressed
only in females [16]. Tra, which binds
RNA weakly by itself, interacts with
Tra2 to promote the cooperative
binding of RBP1 and Tra2 to the dsx
splicing enhancer. The resulting
stable splicing enhancer complex
then recruits the splicing machinery
to the intrinsically weak female-
specific 3′ splice site located upstream
from the enhancer (Figure 1c). 
These observations suggest that
SR proteins work as locators as
defined by Ptashne and Gann [1]. An
interesting prediction following on
from this idea is that artificially
tethering a component of the
splicing machinery near a splice site
— an experiment analogous to an
‘activator bypass’ experiment — will
suffice for splicing enhancer activity.
That prediction is now being tested.
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Figure 1
Localization of the splicing machinery by
splicing regulators. (a) An SR protein bound
to a splicing enhancer, located in the exon
downstream of the regulated intron, recruits
the splicing machinery to the adjacent intron.
(b) A hybrid protein containing an RS domain
fused to the bacteriophage MS2 RNA-
binding protein can recruit the splicing
machinery to an intron when bound to an
MS2 RNA-binding site located within exon 2.
(c) Regulated assembly of a splicing
enhancer complex by cooperative binding
interactions. The SR protein RBP1 and the
splicing regulators Tra, which is expressed
only in female flies, and Tra2 cooperatively
interact to form a stable splicing enhancer
complex on the dsx splicing enhancer. This
enhancer complex recruits the splicing
machinery to the upstream female-specific 3′
splice site in the dsx pre-mRNA.
Exon 1 Exon 2
SR
Exon 1 Exon 2
Exon 1 Exon 2
Splicing
machinery
Splicing
machinery
Splicing
machinery
MS2
RS
Tra2
Tra2
Tra
Tra
RBP1
RBP1
5′ splice 
site
3′ splice 
site
Splicing
enhancer
MS2 
binding
site
dsx splicing
enhancer
Current Biology   
5′ splice 
site
3′ splice 
site
5′ splice 
site
3′ splice 
site
(a)
(b)
(c)
The editors of Current Biology welcome
correspondence on any article in the
journal, but reserve the right to reduce
the length of any letter to be published.
All Correspondence containing data or
scientific argument will be refereed.
